Labiotech.eu

News and Trends 1 Jun 2022

MiRXES opens Southeast Asia’s first industry 4.0 IVD manufacturing facility

Singapore biotech firm MiRXES Pte Ltd, which focuses on early detection cancer tests, has opened the first industry 4.0 (i4.0) in vitro diagnostic (IVD) manufacturing facility in Southeast Asia. The S$8M (US$5.8M) 15,000-square-feet facility is located at JTC MedTech Hub. The company said the site is close to the biomedical R&D community at Biopolis, pharmaceutical […]

June 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

Chinese biotech company looks to help global monkeypox drug development

Shanghai Zelixir Biotech Company Ltd. has predicted more than 600 structures and added functional annotations of proteins from monkeypox virus proteomes, which is the complete set of proteins present at a given time in the cell. The company hopes the predicted structures will help the global quest to develop monkeypox vaccines. Monkeypox cases have grown […]

June 1, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

New treatment option available for Dravet syndrome

Global biopharma company UCB says the UK’s National Institute for Healthcare Excellence (NICE) has issued a positive Final Appraisal Determination (FAD) for its FINTEPLA (fenfluramine) oral solution. FINTEPLA is used for the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients two years of age and older. […]

June 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax

GSK plc is set to acquire Affinivax, Inc., a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1B upfront payment and up to $1.2B in potential development milestones. Affinivax is developing a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines. Pneumococcal disease includes pneumonia, meningitis, bloodstream infections, and […]

June 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 31 May 2022

Therapeutic RNA company receives additional funding

UK biotech company Transine Therapeutics, which is developing a novel class of therapeutic RNAs, has successfully raised £4.6M ($5.8M) in additional seed funding. The financing was led by new investor Epidarex Capital with participation from existing investor the Dementia Discovery Fund (DDF). Transine said the additional funds will enable it to further develop its SINEUP […]

May 31, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 31 May 2022

Evotec adds cell therapy manufacturing facility through Rigenerand takeover

German headquartered life science company Evotec SE has acquired 100% of the capital of Rigenerand Srl, an Italian cell technology company, for €23M ($24.7M). Founded in 2009 as a spin-off of the University of Modena and Reggio Emilia in Italy, Rigenerand is based in Medolla, Italy, about 100 km south of Evotec’s Campus Levi-Montalcini in […]

May 31, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 31 May 2022

Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments

UK neuroscience company NRG Therapeutics Ltd has received a Biomedical Catalyst (BMC) award to fund preclinical development of its small molecule disease-modifying medicines for the treatment of Parkinson’s disease, motor neuron disease (MND) and other debilitating chronic neurodegenerative disorders. The £2.68M ($5.8M) early-stage BMC award part-funded by the government-backed agency Innovate UK will support a […]

May 31, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 31 May 2022

ANGLE and U.S. urology group to undertake prostate cancer study

ANGLE plc has signed a master clinical study agreement with Solaris Health Holdings, LLC and joinder agreements with MidLantic Urology LLC, to collaborate and conduct clinical studies in prostate cancer and as a potential route to market in the U.S. Alongside Solaris affiliate MidLantic Urology, UK-headquartered ANGLE will initiate clinical studies aimed at detecting prostate […]

May 31, 2022 - 5 minutesmins - By Jim Cornall

web3 decentralized autonomous organization vitaDAO biotech

In Depth 30 May 2022

Decentralized autonomous organizations are changing how biotechs are run

Built on the emerging ecosystems of Web3 and blockchain, decentralized autonomous organizations (DAOs) allow communities to collectively fund and advance biotech research. The majority of biotech companies are highly centralized with much of the data siloed away in their proprietary databases. Companies have no incentives to openly share this data, which slows down progress in […]

May 30, 2022 - 8 minutesmins - By Sachin Rawat

News and Trends 27 May 2022

Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites

Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two new U.S. sites. The new facilities are located at Indiana’s LEAP Lebanon Innovation and Research District in Boone County. David A. Ricks, Lilly’s chair and CEO, said: “These new sites will add capacity in support of our growing pipeline of […]

May 27, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 27 May 2022

HotSpot looks to boost cancer therapy pipeline with Excelra partnership

U.S. biotech company HotSpot Therapeutics, Inc. is looking to increase its drug development and discovery efforts by partnering with Indian data and digital insights company Excelra. HotSpot discovers and develops small molecule allosteric therapies for the treatment of cancer and autoimmune diseases. What are allosteric therapies? In the journal ACS Medicinal Chemistry Letters, Ahmed F. […]

May 27, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 27 May 2022

Companies partner on early lung cancer detection blood test

U.S. company CorePath Laboratories is partnering with U.K. diagnostics firm Cizzle Biotechnology on an early-stage lung cancer test for the U.S. Lung cancer is the leading cause of cancer deaths in the U.S., making up almost 25% of all cancer deaths. Each year, more people die of lung cancer than of colon, breast, and prostate […]

May 27, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

MiRXES opens Southeast Asia’s first industry 4.0 IVD manufacturing facility

Chinese biotech company looks to help global monkeypox drug development

New treatment option available for Dravet syndrome

GSK to acquire clinical-stage biopharmaceutical company Affinivax

Therapeutic RNA company receives additional funding

Evotec adds cell therapy manufacturing facility through Rigenerand takeover

Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments

ANGLE and U.S. urology group to undertake prostate cancer study

Decentralized autonomous organizations are changing how biotechs are run

Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites

HotSpot looks to boost cancer therapy pipeline with Excelra partnership

Companies partner on early lung cancer detection blood test

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!